Stephen J. Carriere - 29 Sep 2021 Form 3 Insider Report for Evelo Biosciences, Inc.

Role
Principal Accounting Officer
Signature
/s/ Daniel S. Char, Attorney-in-Fact for Stephen J. Carriere
Issuer symbol
EVLO on OTC
Transactions as of
29 Sep 2021
Net transactions value
$0
Form type
3
Filing time
29 Sep 2021, 16:36:38 UTC
Next filing
21 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding EVLO Stock Option (Right to Buy) 29 Sep 2021 Common Stock 75,000 $11.22 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of underlying shares will vest on 1st anniversary of employment commencement date (i.e., September 1, 2022), and remaining 75% of underlying shares will vest in 36 substantially equal monthly installments thereafter.

Remarks:

Exhibit 24 - Power of Attorney